Nicholas Fidelman, MD

Interventional radiologist

Clinics

Radiology at Divisadero St.
1600 Divisadero St., Room A-142 and A-219
San Francisco, CA 94115
Scheduling: (415) 353-2573
CT, MRI and Bone Densitometry: (415) 885-7282
X-Ray and Nuclear Medicine:
(415) 885-3822
Interventional Radiology:
(415) 885-3578
Fax: (415) 353-7299

Hours: Monday to Friday,
8 a.m. – 5 p.m.

Board Certification

Vascular & Interventional Rad, American Board of Radiology

Academic Title

Associate Professor

More about Nicholas Fidelman

Additional Languages

Russian

Education

UCSF School of Medicine 2002

Residencies

UCSF Medical Center, Radiology 2007

Fellowships

UCSF Medical Center, Inteventional Radiology 2008

Selected Research and Publications

  1. ACR Appropriateness CriteriaŽ Radiologic Management of Mesenteric Ischemia. J Am Coll Radiol. 2017 May; 14(5S):S266-S271.
  2. Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Lehrman ED, Fidelman N, Conrad M, LaBerge JM, Kerlan RK, Gould R. Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform. J Vasc Interv Radiol. 2017 Aug; 28(8):1129-1135.e1.
  3. Kohi MP, Kohlbrenner R, Kolli KP, Lehrman E, Taylor AG, Fidelman N. Catheter directed interventions for acute deep vein thrombosis. Cardiovasc Diagn Ther. 2016 Dec; 6(6):599-611.
  4. Peter Lokken R, Fidelman N, Pallav Kolli K, Kerlan RK. Letters to the Editor. J Vasc Interv Radiol. 2016 12; 27(12):1938-1939.
  5. Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874.
  6. Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival. Cardiovasc Intervent Radiol. 2017 Jan; 40(1):69-80.
  7. Lokken RP, Fidelman N, Kolli KP, Kerlan RK. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries. J Vasc Interv Radiol. 2016 Nov; 27(11):1698-1704.
  8. Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY). 2016 05; 41(5):963-9.
  9. Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl. 2016 Feb; 22(2):178-87.
  10. Yao FY, Fidelman N. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging? Hepatology. 2016 Mar; 63(3):1014-25.
  11. Kohi MP, Fidelman N, Behr S, Taylor AG, Kolli K, Conrad M, Hwang G, Weinstein S. Periprocedural Patient Care. Radiographics. 2015 Oct; 35(6):1766-78.
  12. Kohi MP, Rizzuto GA, Fidelman N, Lucero J, Thiet MP. Retained Placenta Accreta Mimicking Choriocarcinoma. Case Rep Pathol. 2015; 2015:167986.
  13. Fidelman N, Kerlan RK. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. AJR Am J Roentgenol. 2015 Oct; 205(4):742-52.
  14. Olorunsola OG, Kohi MP, Behr SC, Kolli PK, Taylor AG, Tong RT, LaBerge JM, Kerlan RK, Fidelman N. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization. J Vasc Interv Radiol. 2015 Oct; 26(10):1472-8.
  15. Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK, Agarwal VK, Lehrman ED, Nanavati S, Avrin DE, Gould R. Patient Radiation Dose Reduction during Transarterial Chemoembolization Using a Novel X-Ray Imaging Platform. J Vasc Interv Radiol. 2015 Sep; 26(9):1331-8.
  16. Kohi MP, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Crossed legs: an unexpected occurrence during an ALN filter placement. Clin Imaging. 2015 Nov-Dec; 39(6):1128-9.
  17. Fidelman N. Benign Biliary Strictures: Diagnostic Evaluation and Approaches to Percutaneous Treatment. Tech Vasc Interv Radiol. 2015 Dec; 18(4):210-7.
  18. Bartolome B, Kohi MP, Fidelman N, Taylor AG, Kolli KP, LaBerge JM, Kerlan RK. Hemothorax resulting from injury to the right inferior phrenic artery following transhepatic procedures. J Vasc Interv Radiol. 2015 Apr; 26(4):600-1.
  19. Young K, Fidelman N, Yao FY, Hills NK, Kohi MP, Kolli KP, Taylor AG, Kerlan RK. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl. 2015 Apr; 21(4):454-67.
  20. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.